{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:04Z","timestamp":1793214604716,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11926-020-0885-y","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T22:02:36Z","timestamp":1585260156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy"],"prefix":"10.1007","volume":"22","author":[{"given":"Alana","family":"Nevares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonita","family":"Libman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula","family":"Hajj-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"885_CR1","unstructured":"Gartner LP, Hiatt JL. Concise histology. Philadelphia: Saunders\/Elsevier; 2011."},{"key":"885_CR2","unstructured":"Yanoff M, Duker JS. Ophthalmology. 5th ed. New York: Elsevier; 2019."},{"issue":"3","key":"885_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163\u201391. https:\/\/doi.org\/10.1136\/bjo.60.3.163.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"885_CR4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","volume":"32","author":"G Honik","year":"2013","unstructured":"Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in northern California. Cornea. 2013;32(12):1562\u20136. https:\/\/doi.org\/10.1097\/ICO.0b013e3182a407c3.","journal-title":"Cornea."},{"issue":"4","key":"885_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ajo.2013.05.026","volume":"156","author":"G Homayounfar","year":"2013","unstructured":"Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, et al. Incidence of scleritis and episcleritis: results from the Pacific ocular inflammation study. Am J Ophthalmol. 2013;156(4):752\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2013.05.026.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"885_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","volume":"119","author":"M Sainz de la Maza","year":"2012","unstructured":"Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43\u201350. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.013.","journal-title":"Ophthalmology"},{"issue":"4","key":"885_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469\u201376. https:\/\/doi.org\/10.1016\/s0002-9394(00)00710-8.","journal-title":"Am J Ophthalmol"},{"key":"885_CR8","doi-asserted-by":"publisher","unstructured":"Clavel G, Gabison E, Semerano L. Corneal and scleral involvement in inflammatory rheumatic disease: rheumatologists and ophthalmologists exchanging views. Joint Bone Spine. 2019. https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.014.","DOI":"10.1016\/j.jbspin.2019.01.014"},{"key":"885_CR9","unstructured":"Bowling B, Kanski JJ. Kanski\u2019s clinical ophthalmology: a systematic approach. 8th ed. London: Elsevier; 2016."},{"issue":"7","key":"885_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/s0161-6420(99)00719-8","volume":"106","author":"WP Riono","year":"1999","unstructured":"Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106(7):1328\u201333. https:\/\/doi.org\/10.1016\/s0161-6420(99)00719-8.","journal-title":"Ophthalmology."},{"issue":"5","key":"885_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jclinpath-2018-205360","volume":"72","author":"M Hankins","year":"2019","unstructured":"Hankins M, Margo CE. Histopathological evaluation of scleritis. J Clin Pathol. 2019;72(5):386\u201390. https:\/\/doi.org\/10.1136\/jclinpath-2018-205360.","journal-title":"J Clin Pathol"},{"issue":"3","key":"885_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","volume":"111","author":"EK Akpek","year":"2004","unstructured":"Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2003.06.006.","journal-title":"Ophthalmology."},{"issue":"12","key":"885_CR13","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.ophtha.2014.06.033","volume":"121","author":"A Iovieno","year":"2014","unstructured":"Iovieno A, Gore DM, Carnt N, Dart JK. Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes. Ophthalmology. 2014;121(12):2340\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2014.06.033.","journal-title":"Ophthalmology."},{"issue":"6","key":"885_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/bjo.2004.060152","volume":"89","author":"BJ Burton","year":"2005","unstructured":"Burton BJ, Cunningham ET Jr, Cree IA, Pavesio CE. Eye involvement mimicking scleritis in a patient with chronic lymphocytic leukaemia. Br J Ophthalmol. 2005;89(6):775\u20136. https:\/\/doi.org\/10.1136\/bjo.2004.060152.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"885_CR15","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/iop.0000000000000720","volume":"33","author":"M Sharma","year":"2017","unstructured":"Sharma M, Sundar D, Vanathi M, Meel R, Kashyap S, Chawla R, et al. Invasive ocular surface squamous neoplasia masquerading as nodular Scleritis. Ophthalmic Plast Reconstr Surg. 2017;33(2):e45\u2013e7. https:\/\/doi.org\/10.1097\/iop.0000000000000720.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"885_CR16","doi-asserted-by":"publisher","first-page":"E431","DOI":"10.1503\/cmaj.111752","volume":"184","author":"M Etminan","year":"2012","unstructured":"Etminan M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. Cmaj. 2012;184(8):E431\u20134. https:\/\/doi.org\/10.1503\/cmaj.111752.","journal-title":"Cmaj."},{"issue":"2","key":"885_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3899\/jrheum.110865","volume":"39","author":"C Gaujoux-Viala","year":"2012","unstructured":"Gaujoux-Viala C, Giampietro C, Gaujoux T, Ea HK, Prati C, Orcel P, et al. Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease. J Rheumatol. 2012;39(2):233\u20139. https:\/\/doi.org\/10.3899\/jrheum.110865.","journal-title":"J Rheumatol"},{"key":"885_CR18","doi-asserted-by":"crossref","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102(4):687\u201392.","DOI":"10.1016\/S0161-6420(95)30970-0"},{"issue":"7","key":"885_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0161-6420(94)31178-X","volume":"101","author":"M Sainz de la Maza","year":"1994","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101(7):1281\u20136. discussion 7-8.","journal-title":"Ophthalmology."},{"issue":"1","key":"885_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/ard.48.1.7","volume":"48","author":"CC Erhardt","year":"1989","unstructured":"Erhardt CC, Mumford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis. 1989;48(1):7\u201313. https:\/\/doi.org\/10.1136\/ard.48.1.7.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"885_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","volume":"91","author":"CS Foster","year":"1984","unstructured":"Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984;91(10):1253\u201363.","journal-title":"Ophthalmology."},{"issue":"5","key":"885_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3899\/jrheum.170437","volume":"45","author":"C Caimmi","year":"2018","unstructured":"Caimmi C, Crowson CS, Smith WM, Matteson EL, Makol A. Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era. J Rheumatol. 2018;45(5):595\u2013603. https:\/\/doi.org\/10.3899\/jrheum.170437. This single center study reported the clinical characteristics of inflammatory ocular disease in rheumatoid arthritis, extra-skeletal manifestations and mortality in the post-biologic era.","journal-title":"J Rheumatol"},{"issue":"1","key":"885_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0002-9343(77)90125-5","volume":"63","author":"BF Haynes","year":"1977","unstructured":"Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener\u2019s granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63(1):131\u201341. https:\/\/doi.org\/10.1016\/0002-9343(77)90125-5.","journal-title":"Am J Med"},{"issue":"6","key":"885_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488\u201398. https:\/\/doi.org\/10.7326\/0003-4819-116-6-488.","journal-title":"Ann Intern Med"},{"issue":"8","key":"885_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/bjophthalmol-2015-307460","volume":"100","author":"L Cocho","year":"2016","unstructured":"Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Sainz-de-la-Maza M, Foster CS. Scleritis in patients with granulomatosis with polyangiitis (Wegener). Br J Ophthalmol. 2016;100(8):1062\u20135. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307460.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"885_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","volume":"42","author":"PR Rothschild","year":"2013","unstructured":"Rothschild PR, Pagnoux C, Seror R, Brezin AP, Delair E, Guillevin L. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42(5):507\u201314. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.08.003.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"885_CR27","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/rheumatology\/kex261","volume":"56","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Cartin-Ceba R, Garrity JA, Smith WM, Specks U, et al. Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study. Rheumatology (Oxford). 2017;56(10):1763\u201370. https:\/\/doi.org\/10.1093\/rheumatology\/kex261.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"885_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","volume":"3","author":"AS Watkins","year":"2009","unstructured":"Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, et al. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor. 2009;3(1):12\u20139. https:\/\/doi.org\/10.1007\/s12177-009-9044-4.","journal-title":"J Ocul Biol Dis Infor"},{"issue":"9","key":"885_CR29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1136\/bjophthalmol-2015-306902","volume":"100","author":"M Sainz-de-la-Maza","year":"2016","unstructured":"Sainz-de-la-Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis associated with relapsing polychondritis. Br J Ophthalmol. 2016;100(9):1290\u20134. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306902.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"885_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12664-015-0598-8","volume":"34","author":"D Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, et al. Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015;34(5):387\u201394. https:\/\/doi.org\/10.1007\/s12664-015-0598-8.","journal-title":"Indian J Gastroenterol"},{"issue":"4","key":"885_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10067-007-0797-5","volume":"27","author":"CC Lanna","year":"2008","unstructured":"Lanna CC, Ferrari Mde L, Rocha SL, Nascimento E, de Carvalho MA, da Cunha AS. A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol. 2008;27(4):503\u20139. https:\/\/doi.org\/10.1007\/s10067-007-0797-5.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"885_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","volume":"10","author":"K Karmiris","year":"2016","unstructured":"Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10(4):429\u201336. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv232.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"885_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09273948.2017.1386791","volume":"27","author":"P Ungprasert","year":"2019","unstructured":"Ungprasert P, Tooley AA, Crowson CS, Matteson EL, Smith WM. Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013. Ocul Immunol Inflamm. 2019;27(3):389\u201395. https:\/\/doi.org\/10.1080\/09273948.2017.1386791.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"885_CR34","first-page":"452","volume":"36","author":"K Ohara","year":"1992","unstructured":"Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992;36(4):452\u20137.","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"885_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00417-004-1023-7","volume":"243","author":"W Saito","year":"2005","unstructured":"Saito W, Kotake S, Ohno S. A patient with sarcoidosis diagnosed by a biopsy of scleral nodules. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):374\u20136. https:\/\/doi.org\/10.1007\/s00417-004-1023-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"885_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09273940490895353","volume":"12","author":"D Dursun","year":"2004","unstructured":"Dursun D, Akova YA, Bilezikci B. Scleritis associated with sarcoidosis. Ocul Immunol Inflamm. 2004;12(2):143\u20138. https:\/\/doi.org\/10.1080\/09273940490895353.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"885_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/09273948.2013.805786","volume":"22","author":"M Hessen","year":"2014","unstructured":"Hessen M, Eberhart C, Butler N, Akpek EK. Sarcoidosis presenting as scleral nodule. Ocul Immunol Inflamm. 2014;22(4):311\u20133. https:\/\/doi.org\/10.3109\/09273948.2013.805786.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"885_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/09273948.2012.709574","volume":"20","author":"YM Paulus","year":"2012","unstructured":"Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D. IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report. Ocul Immunol Inflamm. 2012;20(5):375\u20137. https:\/\/doi.org\/10.3109\/09273948.2012.709574.","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"885_CR39","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1111\/aos.13376","volume":"95","author":"F Karim","year":"2017","unstructured":"Karim F, de Hoog J, Paridaens D, Verdijk R, Schreurs M, Rothova A, et al. IgG4-related disease as an emerging cause of scleritis. Acta Ophthalmol. 2017;95(8):e795\u2013e6. https:\/\/doi.org\/10.1111\/aos.13376.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"885_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09286580701585892","volume":"15","author":"JH Kempen","year":"2008","unstructured":"Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kacmaz RO, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the systemic immunosuppressive therapy for eye diseases (SITE) cohort study. Ophthalmic Epidemiol. 2008;15(1):47\u201355. https:\/\/doi.org\/10.1080\/09286580701585892.","journal-title":"Ophthalmic Epidemiol"},{"issue":"11","key":"885_CR41","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL, Kacmaz RO, Jabs DA, Levy-Clarke GA, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188\u201398.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2009.04.020.","journal-title":"Ophthalmology"},{"issue":"4","key":"885_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"S Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148(4):500\u20139.e2. https:\/\/doi.org\/10.1016\/j.ajo.2009.05.008.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"885_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","volume":"149","author":"E Daniel","year":"2010","unstructured":"Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kacmaz RO, Levy-Clarke GA, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423\u201332.e1\u20132. https:\/\/doi.org\/10.1016\/j.ajo.2009.09.026.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"885_CR44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","volume":"121","author":"EB Suhler","year":"2014","unstructured":"Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, et al. Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014;121(10):1885\u201391. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.044. This small randomized trial showed efficacy of ritxuimab on the treatment of refractory scleritis.","journal-title":"Ophthalmology"},{"key":"885_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajo.2015.12.032","volume":"164","author":"JH Cao","year":"2016","unstructured":"Cao JH, Oray M, Cocho L, Foster CS. Rituximab in the treatment of refractory noninfectious scleritis. Am J Ophthalmol. 2016;164:22\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2015.12.032.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"885_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bjo.2008.150961","volume":"94","author":"P Doctor","year":"2010","unstructured":"Doctor P, Sultan A, Syed S, Christen W, Bhat P, Foster CS. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010;94(5):579\u201383. https:\/\/doi.org\/10.1136\/bjo.2008.150961.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"885_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/09273948.2015.1134581","volume":"25","author":"K Durrani","year":"2017","unstructured":"Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, et al. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2017;25(3):405\u201312. https:\/\/doi.org\/10.3109\/09273948.2015.1134581.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"885_CR48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2014","unstructured":"Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785\u201396.e3. https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.048.","journal-title":"Ophthalmology"},{"issue":"6","key":"885_CR49","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1111\/aos.13015","volume":"94","author":"S Silpa-Archa","year":"2016","unstructured":"Silpa-Archa S, Oray M, Preble JM, Foster CS. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmol. 2016;94(6):e400\u20136. https:\/\/doi.org\/10.1111\/aos.13015.","journal-title":"Acta Ophthalmol"},{"key":"885_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajo.2016.09.017","volume":"172","author":"JE Knickelbein","year":"2016","unstructured":"Knickelbein JE, Tucker WR, Bhatt N, Armbrust K, Valent D, Obiyor D, et al. Gevokizumab in the treatment of autoimmune non-necrotizing anterior Scleritis: results of a phase I\/II clinical trial. Am J Ophthalmol. 2016;172:104\u201310. https:\/\/doi.org\/10.1016\/j.ajo.2016.09.017.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"885_CR51","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/09273948.2017.1299869","volume":"26","author":"C Bottin","year":"2018","unstructured":"Bottin C, Fel A, Butel N, Domont F, Remond AL, Savey L, et al. Anakinra in the treatment of patients with refractory Scleritis: a pilot study. Ocul Immunol Inflamm. 2018;26(6):915\u201320. https:\/\/doi.org\/10.1080\/09273948.2017.1299869.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"885_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","volume":"117","author":"SS Pujari","year":"2010","unstructured":"Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010;117(2):356\u201365. https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.060.","journal-title":"Ophthalmology."},{"issue":"3","key":"885_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa0909905.","journal-title":"N Engl J Med"},{"issue":"10","key":"885_CR54","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.ophtha.2005.05.008","volume":"112","author":"TA Albini","year":"2005","unstructured":"Albini TA, Zamir E, Read RW, Smith RE, See RF, Rao NA. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology. 2005;112(10):1814\u201320. https:\/\/doi.org\/10.1016\/j.ophtha.2005.05.008.","journal-title":"Ophthalmology."},{"issue":"5","key":"885_CR55","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/s0161-6420(95)30963-3","volume":"102","author":"EY Tu","year":"1995","unstructured":"Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995;102(5):718\u201324. https:\/\/doi.org\/10.1016\/s0161-6420(95)30963-3.","journal-title":"Ophthalmology."},{"key":"885_CR56","volume-title":"The sclera and systemic disorders","author":"PW Watson","year":"1976","unstructured":"Watson PW, Hazleman BL. The sclera and systemic disorders. Philadelphia: Saunders; 1976."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-020-0885-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T20:25:03Z","timestamp":1616703903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-020-0885-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["885"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-0885-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"26 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"11"}}